EA
ELV icon

Emerald Acquisition’s Elevance Health ELV Stock Holding History

Emerald Acquisition’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$158M Sell
1,263,784
-586,776
-32% -$75.8M 0.31% 59
2016
Q2 		$243M Buy
+1,850,560
New +$253M 0.42% 33

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Emerald Acquisition's ELV Position: Q3 2016 in Review

Emerald Acquisition reduced its Elevance Health (ELV) stake by 32% in Q3 2016, selling an estimated $75.8M and leaving 1,263,784 shares worth $158M. The position accounts for 0.31% of the portfolio, ranked #59.

Emerald Acquisition first reported a position in ELV in Q2 2016 and has held it in 2 quarters since. The position peaked at $243M in Q2 2016. 734 funds tracked by Wall St. Rank hold ELV as of Q3 2016.

  • Emerald Acquisition held 1,263,784 shares of Elevance Health worth $158M as of Q3 2016.
  • Emerald Acquisition sold 586,776 Elevance Health shares in Q3 2016, an estimated $75.8M.
  • Elevance Health made up 0.31% of Emerald Acquisition's portfolio in Q3 2016, its #59 holding.
  • Emerald Acquisition first reported a position in Elevance Health in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Elevance Health position peaked at $243M in Q2 2016.
  • 734 funds tracked by Wall St. Rank held Elevance Health as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.